For an older person with type 2 diabetes, especially someone already at risk of frailty, a GLP 1 or SGLT 2 medicine, where ...

Millions of adults remain confused about dietary requirements for people with Type 2 diabetes, with 20% believing they must ...

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify adults who could benefit from new drugs, ...

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to ...

A new analysis suggests GLP 1 receptor agonists, the diabetes drugs that include semaglutide, dulaglutide and liraglutide, ...

Regulators in the UK and US are the first to approve GSK's Exdensur, a long-acting, twice-yearly IL-5 inhibitor for severe ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to ...

Discover how consuming mangoes, despite their sugar content, can positively influence blood glucose levels and aid in ...

Spending too long sitting raises the risk of heart disease and diabetes in people over 60, warns a major global review.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...